Nuwellis Inc. recently faced a potential delisting from the Nasdaq Stock Market due to its common stock bid price closing below $1.00 per share for 30 consecutive trading days. However, as of July 22, 2025, Nuwellis received confirmation from Nasdaq that the minimum bid price deficiency had been resolved, bringing the company back into compliance with the listing standards. Consequently, the scheduled hearing before the Nasdaq Hearings Panel on August 12, 2025, was deemed unnecessary and canceled. Nasdaq has decided to continue listing Nuwellis' common stock on The Nasdaq Capital Market.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.